Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia

Int J Hematol. 2018 Apr;107(4):390-391. doi: 10.1007/s12185-017-2377-z. Epub 2017 Nov 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects
  • Biomarkers / blood
  • Child
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Humans
  • Induction Chemotherapy / adverse effects*
  • Male
  • Non-alcoholic Fatty Liver Disease / chemically induced*
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / pathology
  • Obesity / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Tomography, X-Ray Computed
  • Vincristine / administration & dosage
  • Vincristine / adverse effects
  • gamma-Glutamyltransferase / blood

Substances

  • Biomarkers
  • Vincristine
  • gamma-Glutamyltransferase
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol